StockData
Mangoceuticals, Inc. logo

Mangoceuticals, Inc. (MGRX) stock

MGRXNasdaqServices-Misc Health & Allied Services, NECFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 7/30
$0.16−0.00 (-0.19%)

Close on Nov 17, 2026Market cap $3.45MP/E –Yield –

Mangoceuticals price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Mangoceuticals's price to sales ratio was 11.4× on Nov 11, 2026, against 33.0× a year earlier. Over the last 3 years it ranged from 5.3× to 48.7×, with a median of 12.5×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202611.4×−10.6
2025Dec 31, 202522.0×+15.2
2024Dec 31, 20246.8×–

More Mangoceuticals figures

See a number that looks wrong?